Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,545.5
-13.6 (-0.53%)

 

  • STI Straits Times Index
    2,545.5
    -13.6 (-0.53%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,578.1
    -10.4 (-0.66%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,531.6
    -399.0 (-1.60%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,354.0
    -32.4 (-0.96%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,329.9
    -88.2 (-0.39%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,143.9
    -34.4 (-0.66%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,268.2M
  • Value: 1,358.8M
  • Rise: 113
  • Fall: 217
  • Unch: 478

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.008+0.001
ThaiBev0.605-0.020
Genting Sing0.680-0.030
Asian Healthcare0.285+0.050
Vicplas Intl0.390+0.065
ISDN0.395+0.030
AsiaMedic0.023+0.002
CNMC Goldmine0.360+0.015
Rex Intl0.184-0.003
Medtecs Intl0.970-0.030

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

BLUEBIRD BIO INC BLUEBIRD BIO
Updated on 06 Aug 2020 (End of trading day)
Last (USD): 63.840 Change: +1.780 High: 68.390 Remarks: -
Change (%): +2.87 Low: 62.870
Open 63.200 Yesterday's Close 62.06
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,545,688 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -12.19604 Trailing EPS (USD) e -12.78552 NAV (USD) b -
PE a - Trailing PE f - Price / NAV b -
Dividend (USD) d - Cash In Hand (USD) g 18.5158 Issued & Paid-up Shares c 64,743,000
Dividend Yield (%) d - Price / Cash In Hand g 3.448 Treasury Shares h -
Market Cap (M) 4,133.193 Enterprise Value (M) 2,779.330
Piotroski F Score 0 Exchange Code BLUE Par Value ( $ ) n.a.
52 Weeks Volatility (%) 64.97 Free Float (%) 99.0
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 20 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference BLUEBIRD BIO INC NASDAQ 4,133.193 - - - -
Industry Biotechnology NASDAQ 2,901.168 416.645 6455.431 8.4322 0.645
Local Peer AMGEN INC NASDAQ 141,474.386 18.041 19.383 13.2728 2.425
Local Peer GILEAD SCIENCES INC NASDAQ 86,313.200 16.025 - 4.7577 3.696
Local Peer VERTEX PHARMACEUTICAL NASDAQ 71,196.050 60.499 34.216 9.4685 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 66,091.756 31.237 33.506 - -
Local Peer ILLUMINA INC NASDAQ 58,701.510 58.584 62.316 12.6648 -
Local Peer BIOGEN INC NASDAQ 43,957.188 7.465 7.417 3.8870 -
Local Peer MODERNA INC NASDAQ 28,679.658 - - - -
Local Peer SEATTLE GENETICS INC NASDAQ 28,152.715 - - 15.5190 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,772.075 9.471 26.914 2.1707 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 21,698.528 - 142.875 - -
Local Peer INCYTE CORPORATION NASDAQ 21,268.478 47.590 - 9.0712 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 20,169.680 - - 7.1723 -
Other Local Peers BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NOVAVAX INC (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), ALKERMES PLC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), FATE THERAPEUTICS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VIELA BIO INC (NASDAQ), VERACYTE INC (NASDAQ), UNIQURE N.V. (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), VAXCYTE INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), MACROGENICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), CYTOKINETICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), COMPUGEN (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), EPIZYME INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), CORTEXYME INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ALECTOR INC (NASDAQ), ARVINAS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), TRANSLATE BIO INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), RETROPHIN INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), PRECIGEN INC (NASDAQ), NKARTA INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), OMEROS CORP (NASDAQ), MORPHIC HOLDING INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), IMMUNOGEN INC (NASDAQ), PASSAGE BIO INC (NASDAQ), PERSONALIS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VAXART INC (NASDAQ), AKOUOS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AGENUS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), GERON CORP (NASDAQ), ATHERSYS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ARDELYX INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ANAPTYSBIO INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), XBIOTECH INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), KAMADA (NASDAQ), MERUS B V (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), IVERIC BIO INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), IMV INC (NASDAQ), CABALETTA BIO INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AFFIMED N V (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MEDICINOVA INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), NEXTCURE INC (NASDAQ), TREVENA INC (NASDAQ), CHIASMA INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), VERASTEM INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ADURO BIOTECH INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CHIMERIX INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), XOMA CORP (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), EQUILLIUM INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), INMUNE BIO INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), CONTRAFECT CORP (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), RECRO PHARMA INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), RESTORBIO INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), COHBAR INC (NASDAQ), ARAVIVE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), SYNLOGIC INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), OCUGEN INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), PRECIPIO INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ATYR PHARMA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ADVAXIS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), BIOCARDIA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), EVOGENE LTD (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ)
Global Peer CSL ASX 124,495.695 46.403 42.977 14.3952 0.967
Global Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Global Peer WUXI BIO HKEx 228,464.733 198.740 198.739 15.9759 -
Global Peer SINO BIOPHARM HKEx 183,064.220 59.645 60.190 5.2838 0.548
Global Peer BEIGENE HKEx 156,345.400 - - - -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 6,719.345 123.291 39.456 5.6051 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 31,551.186 - - 10.5642 -
Global Peer 3SBIO HKEx 23,375.225 21.171 21.171 2.1711 -
Global Peer HAOHAI BIOTEC HKEx 21,606.322 51.391 51.391 3.6734 0.631
Other Global Peers VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), MESOBLAST LTD (ASX), MYOVANT SCIENCES LTD (NYSE), ARCUS BIOSCIENCES INC (NYSE), POLYNOVO LIMITED (ASX), ASCENTAGE-B (HKEx), FRONTAGE (HKEx), KINTOR PHARMA-B (HKEx), KADMON HLDGS INC (NYSE), DPHARMA (Bursa), LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), NANOVIRICIDES INC (NYSE American), IBIO INC (NYSE American), ESSEX BIO-TECH (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), TELIX PHARMACEUTIC (ASX), IMUGENE LIMITED (ASX), PFENEX INC (NYSE American), NEXT SCIENCE LTD (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), AIM IMMUNOTECH INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), ANTEOTECH LIMITED (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), MEMPHASYS LTD (ASX), IMMUTEP LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), GENETIC TECHNOLOGIES (ASX), CYNATA THERAPEUTICS LTD (ASX), ORAGENICS INC (NYSE American), BIOTRON (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), CT ENTERPRISE (HKEx), KAZIA THERAPEUTICS LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), BIONOMICS LTD (ASX), BIOSINO BIO-TEC (HKEx), CONSTELLATION TECHNOLOGIES LTD (ASX), Suntar Eco-City (SGX), REGENEUS LTD (ASX), REGENT PACIFIC (HKEx), INDIA GLOBALIZATION CAPITAL INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American), ACTINOGEN MEDICAL LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), RHINOMED LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), PATRYS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CRYOSITE (ASX), LIVING CELL TECHNOLOGIES (ASX), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), HAO WEN H-NEW (HKEx), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), HAO WEN H-OLD (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+3.140
+5.17 %
10 Days --0.400
-0.62 %
20 Days --0.150
-0.23 %
Medium Term Return 3 Months -+4.560
+7.69 %
6 Months --24.810
-27.99 %
1 Year --61.390
-49.02 %
Long Term Return 2 Years --94.360
-59.65 %
3 Years --30.110
-32.05 %
5 Years --63.980
-50.05 %
Annualised Return Annualised --
-12.96 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 38.950 - 126.394 Change From 1 Year Low +24.890 % Change From 1 Year Low (%) +63.90
Change From 1 Year High -62.554 % Change From 1 Year High (%) -49.49
2 Years Range 38.950 - 176.548 Change From 2 Years Low +24.890 % Change From 2 Years Low (%) +63.90
Change From 2 Years High -112.708 % Change From 2 Years High (%) -63.84
5 Years Range 35.370 - 236.167 Change From 5 Years Low +28.470 % Change From 5 Years Low (%) +80.49
Change From 5 Years High -172.327 % Change From 5 Years High (%) -72.97
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Its integrated product platform includes gene therapy, cancer immunotherapy, and gene editing. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Cambridge, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
06 Aug 2020 63.200 68.390 62.870 63.840 1,545,688 -
05 Aug 2020 62.950 63.800 61.905 62.060 473,917 -
04 Aug 2020 63.080 63.510 61.320 62.440 551,694 -
03 Aug 2020 61.000 63.170 59.800 62.780 661,309 -
31 Jul 2020 61.480 61.990 59.472 60.700 800,736 -
30 Jul 2020 62.130 63.240 60.500 61.290 834,899 -
29 Jul 2020 65.390 66.090 61.510 62.340 1,197,376 -
28 Jul 2020 65.910 66.440 65.250 65.760 718,532 -
27 Jul 2020 64.850 65.970 63.780 65.970 558,619 -
24 Jul 2020 64.660 64.760 63.120 64.240 449,310 -
23 Jul 2020 65.300 67.420 64.910 65.260 710,564 -
22 Jul 2020 66.080 66.440 64.615 65.330 338,147 -
21 Jul 2020 67.740 68.150 65.360 65.940 612,947 -
20 Jul 2020 66.380 68.190 66.020 67.550 857,136 -
17 Jul 2020 66.630 67.630 65.820 66.240 805,046 -
16 Jul 2020 65.170 66.740 63.600 66.630 704,949 -
15 Jul 2020 63.700 66.770 63.300 65.910 969,317 -
14 Jul 2020 60.500 62.830 59.370 62.830 608,183 -
13 Jul 2020 64.160 64.520 60.710 60.710 683,342 -
10 Jul 2020 66.120 66.250 63.545 63.990 550,536 -
09 Jul 2020 66.340 67.250 64.470 66.160 760,498 -
08 Jul 2020 64.420 66.640 63.450 66.340 1,130,435 -
Summary
Current 2 Weeks
(24 Jul 2020 to 06 Aug 2020)
64.660 68.390 59.472 63.840 7,792,080 -
Previous 2 Weeks
(10 Jul 2020 to 23 Jul 2020)
66.120 68.390 59.472 65.260 6,840,167 -
4 Weeks from
(11 Jun 2020 to 09 Jul 2020)
66.260 68.390 59.472 66.160 24,781,026 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.